NCT06997718View on ClinicalTrials.gov

Evaluation of the Effects of the Product RV5075A-MF6793 in Diabetic Patients Presenting Foot Xerosis and Superficial Fissures, an Exploratory Study.

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 18, 2025

Primary Completion Date

October 4, 2025

Study Completion Date

October 4, 2025

Conditions
Diabetic Foot Xerosis
Interventions
OTHER

RV5075A MF6793

Twice daily applications on both feet. The product will be applied according to randomization on the entire feet in a sufficient amount.

OTHER

CO5075A

Twice daily applications on both feet. The product will be applied according to randomization on the entire feet in a sufficient amount.

Trial Locations (1)

4200-135

RECRUITING

Inovapotek, Porto

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT06997718 - Evaluation of the Effects of the Product RV5075A-MF6793 in Diabetic Patients Presenting Foot Xerosis and Superficial Fissures, an Exploratory Study. | Biotech Hunter | Biotech Hunter